Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia

This study has been completed.
Information provided by:
Eli Lilly and Company Identifier:
First received: February 10, 2005
Last updated: November 5, 2007
Last verified: November 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2006
  Estimated Primary Completion Date: No date given